We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NJ Compounding Pharmacy Enters Into Consent Decree to Fix Quality Issues
NJ Compounding Pharmacy Enters Into Consent Decree to Fix Quality Issues
June 28, 2013
New Jersey-based compounder Med Prep Consulting entered into a consent decree with the FDA Thursday to fix persistent quality problems, the latest agency tactic aimed at reining in compounding pharmacies.